RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kolon Life Science Stock

Kolon Life Science Equity 2024

Kolon Life Science Equity

137.67 B KRW

Ticker

102940.KQ

ISIN

KR7102940004

In 2024, Kolon Life Science's equity was 137.67 B KRW, a -17.92% increase from the 167.72 B KRW equity in the previous year.

Kolon Life Science Aktienanalyse

What does Kolon Life Science do?

Kolon Life Science ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Kolon Life Science's Equity

Kolon Life Science's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Kolon Life Science's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Kolon Life Science's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Kolon Life Science's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Kolon Life Science’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Kolon Life Science stock

What is the equity of Kolon Life Science this year?

Kolon Life Science has equity of 137.67 B KRW this year.

What was the equity of Kolon Life Science compared to the previous year?

The equity of Kolon Life Science has increased/decreased by -17.92% decreased compared to the previous year.

What impact does a high equity have on investors of Kolon Life Science?

A high equity is advantageous for investors of Kolon Life Science as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Kolon Life Science?

A low equity can be a risk for investors of Kolon Life Science, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Kolon Life Science affect the company?

An increase in equity of Kolon Life Science can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Kolon Life Science affect the company?

A reduction in equity of Kolon Life Science can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Kolon Life Science?

Some factors that can affect the equity of Kolon Life Science include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Kolon Life Science so important for investors?

The equity of Kolon Life Science is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Kolon Life Science take to change the equity?

To change equity, Kolon Life Science can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Kolon Life Science pay?

Over the past 12 months, Kolon Life Science paid a dividend of 133.33 KRW . This corresponds to a dividend yield of about 0.72 %. For the coming 12 months, Kolon Life Science is expected to pay a dividend of 0 KRW.

What is the dividend yield of Kolon Life Science?

The current dividend yield of Kolon Life Science is 0.72 %.

When does Kolon Life Science pay dividends?

Kolon Life Science pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Kolon Life Science?

Kolon Life Science paid dividends every year for the past 0 years.

What is the dividend of Kolon Life Science?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Kolon Life Science located?

Kolon Life Science is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kolon Life Science kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kolon Life Science from 4/21/2017 amounting to 200 KRW, you needed to have the stock in your portfolio before the ex-date on 12/28/2016.

When did Kolon Life Science pay the last dividend?

The last dividend was paid out on 4/21/2017.

What was the dividend of Kolon Life Science in the year 2023?

In the year 2023, Kolon Life Science distributed 0 KRW as dividends.

In which currency does Kolon Life Science pay out the dividend?

The dividends of Kolon Life Science are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kolon Life Science

Our stock analysis for Kolon Life Science Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kolon Life Science Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.